{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:02:01Z","timestamp":1781715721427,"version":"3.54.5"},"reference-count":19,"publisher":"Norwegian Medical Association","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.22.0490","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T05:15:13Z","timestamp":1697778913000},"source":"Crossref","is-referenced-by-count":0,"title":["Behandling av eldre med akutt myelogen leukemi uten allogen stamcelletrans=plantasjon ved Akershus universitetssykehus"],"prefix":"10.4045","volume":"143","author":[{"given":"Torstein","family":"Storlien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders Erik Astrup","family":"Dahm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2023,10,20]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Reikvam\u00a0H, Dalgaard\u00a0J, Johansen\u00a0S et al. Behandling av akutt myelogen leukemi hos eldre. Tidsskr Nor Legeforen 2019; 139. doi: 10.4045\/tidsskr.18.0775. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=31062555&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.4045%2Ftidsskr.18.0775","DOI":"10.4045\/tidsskr.18.0775"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Juliusson\u00a0G, Antunovic\u00a0P, Derolf\u00a0A et al. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood 2009; 113: 4179\u201387. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19008455&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1182%2Fblood-2008-07-172007","DOI":"10.1182\/blood-2008-07-172007"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Shallis\u00a0RM, Wang\u00a0R, Davidoff\u00a0A et al. Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges. Blood Rev 2019; 36: 70\u201387. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=31101526&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.blre.2019.04.005","DOI":"10.1016\/j.blre.2019.04.005"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Wang\u00a0ES. Treating acute myeloid leukemia in older adults. Hematology (Am Soc Hematol Educ Program) 2014; 2014: 14\u201320. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25696830&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1182%2Fasheducation-2014.1.14","DOI":"10.1182\/asheducation-2014.1.14"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"D\u00f6hner\u00a0H, Weisdorf\u00a0DJ, Bloomfield\u00a0CD. Acute Myeloid Leukemia. N Engl J Med 2015; 373: 1136\u201352. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26376137&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1056%2FNEJMra1406184","DOI":"10.1056\/NEJMra1406184"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Ustun\u00a0C, Lazarus\u00a0HM, Weisdorf\u00a0D. To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century. Bone Marrow Transplant 2013; 48: 1497\u2013505. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23645167&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038%2Fbmt.2013.67","DOI":"10.1038\/bmt.2013.67"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Talati\u00a0C, Dhulipala\u00a0VC, Extermann\u00a0MT et al. Comparisons of commonly used front-line regimens on survival outcomes in patients aged 70 years and older with acute myeloid leukemia. Haematologica 2020; 105: 398\u2013406. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=31073071&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.3324%2Fhaematol.2018.208637","DOI":"10.3324\/haematol.2018.208637"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Quint\u00e1s-Cardama\u00a0A, Ravandi\u00a0F, Liu-Dumlao\u00a0T et al. Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemia. Blood 2012; 120: 4840\u20135. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23071272&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1182%2Fblood-2012-06-436055","DOI":"10.1182\/blood-2012-06-436055"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Bories\u00a0P, Bertoli\u00a0S, B\u00e9rard\u00a0E et al. Intensive chemotherapy, azacitidine, or supportive care in older acute myeloid leukemia patients: an analysis from a regional healthcare network. Am J Hematol 2014; 89: E244\u201352. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25195872&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fajh.23848","DOI":"10.1002\/ajh.23848"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Maurillo\u00a0L, Buccisano\u00a0F, Spagnoli\u00a0A et al. Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia. Ann Hematol 2018; 97: 1767\u201374. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=29947973&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007%2Fs00277-018-3374-x","DOI":"10.1007\/s00277-018-3374-x"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"D\u00f6hner\u00a0H, Estey\u00a0E, Grimwade\u00a0D et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 2017; 129: 424\u201347. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27895058&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1182%2Fblood-2016-08-733196","DOI":"10.1182\/blood-2016-08-733196"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"D\u00f6hner\u00a0H, Estey\u00a0EH, Amadori\u00a0S et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010; 115: 453\u201374. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19880497&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1182%2Fblood-2009-07-235358","DOI":"10.1182\/blood-2009-07-235358"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"R\u00f6llig\u00a0C, Bornh\u00e4user\u00a0M, Thiede\u00a0C et al. Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system. J Clin Oncol 2011; 29: 2758\u201365. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21632498&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1200%2FJCO.2010.32.8500","DOI":"10.1200\/JCO.2010.32.8500"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"\u00d6sterroos\u00a0A, Eriksson\u00a0A, Antunovic\u00a0P et al. Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged \u2265\u00a060\u00a0years. Br J Haematol 2020; 189: e13\u20136. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32103493&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fbjh.16410","DOI":"10.1111\/bjh.16410"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Fenaux\u00a0P, Mufti\u00a0GJ, Hellstr\u00f6m-Lindberg\u00a0E et al. Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia. J Clin Oncol 2010; 28: 562\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20026804&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1200%2FJCO.2009.23.8329","DOI":"10.1200\/JCO.2009.23.8329"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Dombret\u00a0H, Seymour\u00a0JF, Butrym\u00a0A et al. International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts. Blood 2015; 126: 291\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25987659&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1182%2Fblood-2015-01-621664","DOI":"10.1182\/blood-2015-01-621664"},{"key":"ref=17","unstructured":"Palmer\u00a0D, Jones\u00a0L. A Remarkable Remission: Treating HMA Refractory Transforming MDS with Single-Agent Low-Dose Cytarabine Leading to an Ongoing Six-Year OS. Case Rep Med 2020; 2020: 1540370. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32110242&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1155%2F2020%2F1540370"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"Hubscher\u00a0E, Sikirica\u00a0S, Bell\u00a0T et al. Patterns of undertreatment among patients with acute myeloid leukemia (AML): considerations for patients eligible for non-intensive chemotherapy (NIC). J Cancer Res Clin Oncol 2021; 147: 3359\u201368. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=34462785&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007%2Fs00432-021-03756-7","DOI":"10.1007\/s00432-021-03756-7"},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"Vaughn\u00a0JE, Buckley\u00a0SA, Walter\u00a0RB. Outpatient care of patients with acute myeloid leukemia: Benefits, barriers, and future considerations. Leuk Res 2016; 45: 53\u20138. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27101148&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.leukres.2016.03.011","DOI":"10.1016\/j.leukres.2016.03.011"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:10:29Z","timestamp":1781712629000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2023\/10\/originalartikkel\/behandling-av-eldre-med-akutt-myelogen-leukemi-uten-allogen-stamcelletransplantasjon-ved-akershus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":19,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2023,10,24]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.22.0490","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,20]]}}}